2:52:27 AM PDT - Wednesday, August 21st, 2019

Mallinckrodt Enrolls First Patient in Liver Disease Study  

By Editor - Tue Aug 13, 12:23 pm

Mallinckrodt (MNK) recruits the first patient in a mid-stage study on MNK-6106 for the treatment of hepatic cirrhosis and hepatic encephalopathy.

Read more from the original source:

Mallinckrodt Enrolls First Patient in Liver Disease Study

Leave a Reply

You must sign in to post a comment.